FDA Inspection 1109486 — Stephen A. Tilles, M.D.

Stephen A. Tilles, M.D. — FEI 3011115179

The FDA completed an inspection of Stephen A. Tilles, M.D. on October 31, 2019 in Seattle, WA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 31, 2019
Fiscal Year
2020
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Seattle, WA (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
752621 CFR 312.62(a)Accountability records
753021 CFR 312.62(b)Case history records- inadequate or inadequate
756021 CFR 312.60FD-1572, protocol compliance